Skip to main content

Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor for the Intensification of Cytostatic Treatment in Advanced Cancer

  • Conference paper
Supportive Care in Cancer Patients II

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 121))

Abstract

Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) is a glycoprotein that stimulates granulocyte and macrophage progenitor cells to form mature colonies of granulocytes and/or macrophages [1–3]. Clinically, GM-CSF may have a role in stimulating myelopoietic regeneration after irradiation, treatment with cytostatic drugs, bone marrow transplantation and other treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Metcalf D, Burgess AW (1982) Clonal analysis of progenitor cell commitment to granulocyte or macrophage production. J Cell Physiol 111: 275

    Article  PubMed  CAS  Google Scholar 

  2. Metcalf D, Merchav S (1982) Effects on GM-CSF deprivation on precursors of granulocytes and macrophages. J Cell Physiol 112: 411

    Article  PubMed  CAS  Google Scholar 

  3. Gasson JC, Weisbart RH, Kaufmann SE (1986) Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science 226: 1339–1342

    Article  Google Scholar 

  4. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welte K, Souza L (1988) Effect of granulocyte-colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318: 1414–1422

    Article  PubMed  CAS  Google Scholar 

  5. Vadhan-Ray S, Buescher S, LeMaistre A, Keating M, Walters R, Ventura C, Hittelmann W, Broxmeyer HE, Gutterman JU (1988) Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor. Blood 72: 134–141

    Google Scholar 

  6. Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D, Fox R (1988) Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet I: 667–672

    Google Scholar 

  7. Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, Jones RB, Shpall EJ, Bast RC, Gilbert CJ, Oette DH (1988) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318: 869–976

    Article  PubMed  CAS  Google Scholar 

  8. Weisbart RH, Gasson JC, Golde DW (1989) Colony-stimulating factors and host defense. Ann Intern Med 110: 297–303

    PubMed  CAS  Google Scholar 

  9. Migliaccio G, Migliaccio AR, Adamson JW (1988) In vitro differentiation of human granulocyte/macrophage and erythroid progenitors: comparative analysis of the influence of recombinant human erythropoietin, G-CSF, GM-CSF, and IL-3 in serum-supplemented and serum-deprived cultures. Blood 72: 248–256

    PubMed  CAS  Google Scholar 

  10. Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU (1988) Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 16: 594–602

    PubMed  CAS  Google Scholar 

  11. Herrmann F, Schulz G, Lindemann A, Meyenburg W, Oster W, Krumwieh D, Mertelsmann R (1989) Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor. J Clin Oncol 7: 159–167

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Schmid, L., Thürlimann, B., Müller, M., Senn, HJ. (1991). Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor for the Intensification of Cytostatic Treatment in Advanced Cancer. In: Senn, HJ., Glaus, A. (eds) Supportive Care in Cancer Patients II. Recent Results in Cancer Research, vol 121. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84138-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84138-5_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-84140-8

  • Online ISBN: 978-3-642-84138-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics